Cutter & CO Brokerage, Inc. Ampio Pharmaceuticals, Inc. Transaction History

Cutter & CO Brokerage, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	SELL	$0.42 - $0.62 $10,500 - $15,500	-25,000 Reduced 46.73%	28,500 $13,000
Q3 2021 Nov 02, 2021	SELL	$1.21 - $1.8 $18,150 - $27,000	-15,000 Reduced 21.9%	53,500 $89,000
Q4 2020 Feb 03, 2021	BUY	$0.75 - $2.76 $32,250 - $118,679	43,000 Added 168.63%	68,500 $109,000
Q2 2020 Aug 10, 2020	BUY	$0.47 - $0.72 $11,985 - $18,360	25,500 New	25,500 $16,000
Q1 2020 May 05, 2020	SELL	$0.36 - $0.74 $9,180 - $18,870	-25,500 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$0.39 - $0.7 $3,120 - $5,600	-8,000 Reduced 23.88%	25,500 $10,000
Q1 2019 Apr 23, 2019	SELL	$0.43 - $0.68 $1,720 - $2,720	-4,000 Reduced 10.67%	33,500 $19,000
Q4 2018 Feb 07, 2019	BUY	$0.39 - $0.7 $14,625 - $26,250	37,500 New	37,500 $15,000
Q3 2018 Oct 12, 2018	SELL	$0.44 - $3.02 $22,000 - $151,000	-50,000 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$2.16 - $3.48 $108,000 - $174,000	50,000 New	50,000 $170,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Cutter & CO Brokerage, Inc., based on Form 13F filings with the SEC.

Stay updated on Cutter & CO Brokerage, Inc. with notifications on news.